Nath Karl A, Kanakiriya Sharan K R, Grande Joseph P, Croatt Anthony J, Katusic Zvonimir S
Division of Nephrology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Am J Pathol. 2003 Jun;162(6):2079-90. doi: 10.1016/S0002-9440(10)64339-8.
We hypothesized that the venous limb of an arteriovenous (AV) fistula would evince up-regulation of genes relevant to vascular remodeling along with neointimal hyperplasia and relevant histological changes. Using the aorto-caval model of an AV fistula model in the rat, we demonstrate marked up-regulation in such proinflammatory genes as monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and endothelin-1, 2 weeks after the creation of the fistula. Neointimal hyperplasia occurred in variable degrees by 5 weeks after establishing the fistula, and by 16 weeks, such neointimal hyperplasia was progressive and pronounced; at this time point, abundant extracellular matrix was also observed. Smooth muscle cells were present in the hyperplastic neointima as evidenced by staining for alpha-smooth muscle actin; ultrastructurally, smooth muscle cells with a synthetic as well as a contractile phenotype were readily observed. Accumulation of extracellular matrix in the model at 16 weeks was accompanied by increased expression of transforming growth factor-beta1 mRNA, the latter finding contrasting with the suppression of transforming growth factor-beta1 mRNA observed in this model at 2 weeks. In summary, we describe marked up-regulation in proinflammatory genes and progressive neointimal formation in the venous vasculature in an AV fistula model in the rat. We suggest that such alteration in gene expression and histological injury, in conjunction with the relative simplicity of this model, offer a new approach in the study of such timely biological and clinically relevant phenomena as differential gene expression in response to hemodynamic forces, processes involved in vascular remodeling, mechanisms of injury in venous bypass grafts, and mechanisms of dysfunction of AV fistulae used in hemodialysis.
我们推测,动静脉(AV)瘘的静脉分支会出现与血管重塑相关的基因上调,同时伴有新生内膜增生及相关组织学变化。利用大鼠AV瘘的主动脉-腔静脉模型,我们发现在造瘘后2周,单核细胞趋化蛋白-1、纤溶酶原激活物抑制剂-1和内皮素-1等促炎基因显著上调。造瘘后5周出现不同程度的新生内膜增生,至16周时,这种新生内膜增生呈进行性且明显;此时,还观察到大量细胞外基质。通过α-平滑肌肌动蛋白染色证实增生的新生内膜中有平滑肌细胞;超微结构观察发现,既有合成表型又有收缩表型的平滑肌细胞。模型在16周时细胞外基质的积聚伴随着转化生长因子-β1 mRNA表达增加,这一结果与该模型在2周时观察到的转化生长因子-β1 mRNA受抑制形成对比。总之,我们描述了大鼠AV瘘模型中静脉血管促炎基因的显著上调和新生内膜的进行性形成。我们认为,这种基因表达改变和组织学损伤,结合该模型的相对简易性,为研究诸如对血流动力学力的差异基因表达、血管重塑过程、静脉旁路移植物损伤机制以及血液透析中使用的AV瘘功能障碍机制等及时的生物学和临床相关现象提供了一种新方法。